Clinical Trial Update: Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301) [Phase 3]

View source ↗

Summary

This entry notes a Phase 3 clinical trial (AR882-301) evaluating the efficacy and safety of AR882 in gout patients. The trial is currently active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Gouty Arthritis
• Hyperuricemia

Drugs mentioned

• AR882

Snippet

Sponsor: Arthrosi Therapeutics | Conditions: Gout, Arthritis, Gouty | Phase 3 | Status: ACTIVE_NOT_RECRUITING